Want to join the conversation?
In 3Q16, $VAR's growth in North America was driven by demand for the TrueBeam platform, including Edge Radiosurgery system and software offerings. Order activity in Latin America continued to be weak due to macroeconomic factors. The company saw good orders growth in China, and also made good progress in Thailand, Vietnam and Indonesia.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?